| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
GMRE Overview
Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
Global Medical REIT Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$15.09 |
| 52 Week High | US$12.11 |
| 52 Week Low | US$16.07 |
| Beta | 0.77 |
| 1 Month Change | -0.59% |
| 3 Month Change | -0.72% |
| 1 Year Change | 14.41% |
| 3 Year Change | 65.64% |
| 5 Year Change | 51.66% |
| Change since IPO | -96.93% |
Recent News & Updates
Global Medical REIT: This Tadpole Has Legs
Most REITs begin as small-caps, and most never grow beyond that status. When a REIT manages to grow out of small-cap status, it is a very significant event, and usually signals a great long-term investment. This article examines Global Medical REIT, which may be making the transition from small-cap to lower mid-cap, from Tadpole to FROG (Fast Rate Of Growth).
Global Medical REIT: Delivers Growth And Income
Global Medical REIT is rapidly gaining size in the medical office space. A low cost of debt and moderating cost of equity are allowing to make accretive acquisitions. This REIT can deliver 10% growth and 5% income over the next year.
Shareholder Returns
| GMRE | US REITs | US Market | |
|---|---|---|---|
| 7D | -2.3% | -0.3% | -0.6% |
| 1Y | 14.4% | 32.5% | 33.8% |
Return vs Industry: GMRE underperformed the US REITs industry which returned 32.5% over the past year.
Return vs Market: GMRE underperformed the US Market which returned 33.8% over the past year.
Price Volatility
| GMRE volatility | |
|---|---|
| GMRE Beta | 0.77 |
| Industry Beta | 0.82 |
| Market Beta | 1 |
Stable Share Price: GMRE is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: GMRE's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 22 | Jeff Busch | https://www.globalmedicalreit.com |
Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
Valuation
Is Global Medical REIT undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: GMRE ($15.09) is trading below our estimate of fair value ($52.38)
Significantly Below Fair Value: GMRE is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: GMRE is unprofitable, so we can't compare its PE Ratio to the US REITs industry average.
PE vs Market: GMRE is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate GMRE's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: GMRE is good value based on its PB Ratio (1.8x) compared to the US REITs industry average (2x).
Future Growth
How is Global Medical REIT forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
31.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GMRE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: GMRE is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: GMRE's is expected to become profitable in the next 3 years.
Revenue vs Market: GMRE's revenue (17.7% per year) is forecast to grow faster than the US market (9.8% per year).
High Growth Revenue: GMRE's revenue (17.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GMRE's Return on Equity is forecast to be high in 3 years time
Past Performance
How has Global Medical REIT performed over the past 5 years?
11.6%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GMRE is currently unprofitable.
Growing Profit Margin: GMRE is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: GMRE is unprofitable, but has reduced losses over the past 5 years at a rate of 11.6% per year.
Accelerating Growth: Unable to compare GMRE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GMRE is unprofitable, making it difficult to compare its past year earnings growth to the REITs industry (3.9%).
Return on Equity
High ROE: GMRE has a negative Return on Equity (0.078%), as it is currently unprofitable.
Financial Health
How is Global Medical REIT's financial position?
Financial Position Analysis
Short Term Liabilities: GMRE's short term assets ($46.7M) exceed its short term liabilities ($37.3M).
Long Term Liabilities: GMRE's short term assets ($46.7M) do not cover its long term liabilities ($525.4M).
Debt to Equity History and Analysis
Debt Level: GMRE's debt to equity ratio (81.7%) is considered high.
Reducing Debt: GMRE's debt to equity ratio has reduced from 581.7% to 81.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable GMRE has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: GMRE is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 45.2% per year.
Dividend
What is Global Medical REIT current dividend yield, its reliability and sustainability?
5.43%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: GMRE's dividend (5.43%) is higher than the bottom 25% of dividend payers in the US market (1.33%).
High Dividend: GMRE's dividend (5.43%) is in the top 25% of dividend payers in the US market (3.6%)
Stability and Growth of Payments
Stable Dividend: GMRE has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: GMRE's dividend payments have increased, but the company has only paid a dividend for 7 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (138.8%), GMRE's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: GMRE's dividends in 3 years are forecast to be covered by earnings (76.3% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
4.3yrs
Average management tenure
CEO
Jeff Busch (61 yo)
4.08yrs
Tenure
US$3,086,109
Compensation
Mr. Jeffrey M. Busch, also known as Jeff, is Chairman of the Board at Theralink Technologies, Inc. (formerly known as OncBioMune Pharmaceuticals, Inc.). since June 2020. He is the Chairman of Avant Diagnos...
CEO Compensation Analysis
Compensation vs Market: Jeff's total compensation ($USD3.09M) is above average for companies of similar size in the US market ($USD2.33M).
Compensation vs Earnings: Jeff's compensation has increased whilst the company is unprofitable.
Leadership Team
Experienced Management: GMRE's management team is considered experienced (4.3 years average tenure).
Board Members
Experienced Board: GMRE's board of directors are considered experienced (5.5 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: GMRE insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 36.7%.
Top Shareholders
Company Information
Global Medical REIT Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Global Medical REIT Inc.
- Ticker: GMRE
- Exchange: NYSE
- Founded: 2011
- Industry: Health Care REITs
- Sector: Real Estate
- Implied Market Cap: US$993.262m
- Market Cap: US$967.448m
- Shares outstanding: 65.91m
- Website: https://www.globalmedicalreit.com
Number of Employees
Location
- Global Medical REIT Inc.
- 2 Bethesda Metro Center
- Suite 440
- Bethesda
- Maryland
- 20814
- United States
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/09/20 22:38 |
| End of Day Share Price | 2021/09/20 00:00 |
| Earnings | 2021/06/30 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.